UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:

September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number: 001-07626

Sensient Technologies Corporation

(Exact name of registrant as specified in its charter)

Wisconsin		39-0561070
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

777 EAST WISCONSIN AVENUE, MILWAUKEE, WISCONSIN 53202-5304

(Address of principal executive offices)

Registrant’s telephone number, including area code:

(414) 271-6755

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.10 per share	SXT	New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☒	Accelerated Filer ☐	Non-Accelerated Filer ☐

Smaller Reporting Company ☐	Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class		Outstanding at October 26, 2022
Common Stock, par value $0.10 per share		42,037,685

Index

PART I.

FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

SENSIENT TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands except per share amounts)

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021

Revenue	$	361,076	$	344,287	$	1,088,303	$	1,039,816
Cost of products sold		239,318		229,216		710,696		697,538
Selling and administrative expenses		74,265		68,113		222,081		212,670
Operating income		47,493		46,958		155,526		129,608
Interest expense		3,672		3,037		9,748		9,792
Earnings before income taxes		43,821		43,921		145,778		119,816
Income taxes		7,773		10,009		34,012		28,300
Net earnings	$	36,048	$	33,912	$	111,766	$	91,516

Weighted average number of common shares outstanding:
Basic		41,896		42,024		41,885		42,140
Diluted		42,242		42,206		42,199		42,287

Earnings per common share:
Basic	$	0.86	$	0.81	$	2.67	$	2.17
Diluted	$	0.85	$	0.80	$	2.65	$	2.16

Dividends declared per common share	$	0.41	$	0.39	$	1.23	$	1.17

See accompanying notes to consolidated condensed financial statements.

Index

SENSIENT TECHNOLOGIES CORPORATION

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021

Comprehensive income	$	8,997	$	18,680	$	56,171	$	79,454

See accompanying notes to consolidated condensed financial statements.

Index

SENSIENT TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands)

	September 30, 2022 (Unaudited)			December 31, 2021
Assets
Current Assets:
Cash and cash equivalents	$	46,579		$	25,740
Trade accounts receivable		287,197			261,121
Inventories		501,382			411,635
Prepaid expenses and other current assets		45,582			42,657

Total current assets		880,740			741,153

Other assets		100,277			92,952
Deferred tax assets		12,912			29,901
Intangible assets, net		14,042			14,975
Goodwill		390,798			420,034
Property, Plant, and Equipment:
Land		28,641			31,028
Buildings		304,928			315,207
Machinery and equipment		705,029			715,344
Construction in progress		55,896			32,801
		1,094,494			1,094,380
Less accumulated depreciation		(654,055	)		(647,902	)
		440,439			446,478

Total assets	$	1,839,208		$	1,745,493

Liabilities and Shareholders’ Equity

Current Liabilities:
Trade accounts payable	$	132,904		$	125,519
Accrued salaries, wages, and withholdings from employees		40,918			40,939
Other accrued expenses		54,283			46,292
Income taxes		5,373			11,016
Short-term borrowings		21,947			8,539

Total current liabilities		255,425			232,305

Deferred tax liabilities		16,489			14,349
Other liabilities		37,736			28,829
Accrued employee and retiree benefits		27,854			28,579
Long-term debt		547,190			503,006
Shareholders’ Equity:
Common stock		5,396			5,396
Additional paid-in capital		120,381			111,352
Earnings reinvested in the business		1,690,813			1,630,713
Treasury stock, at cost		(631,853	)		(634,408	)
Accumulated other comprehensive loss		(230,223	)		(174,628	)

Total shareholders’ equity		954,514			938,425

Total liabilities and shareholders’ equity	$	1,839,208		$	1,745,493

See accompanying notes to consolidated condensed financial statements.

Index

SENSIENT TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended September 30,
	2022			2021

Cash flows from operating activities:
Net earnings	$	111,766		$	91,516
Adjustments to arrive at net cash provided by operating activities:
Depreciation and amortization		39,262			38,828
Share-based compensation expense		12,476			6,431
Net loss on assets		283			203
Loss on divestitures and other charges		-			13,774
Deferred income taxes		20,465			3,793
Changes in operating assets and liabilities:
Trade accounts receivable		(39,520	)		(35,290	)
Inventories		(112,021	)		(15,898	)
Prepaid expenses and other assets		(39,598	)		(15,016	)
Accounts payable and other accrued expenses		24,110			24,007
Accrued salaries, wages, and withholdings from employees		1,819			1,763
Income taxes		(4,342	)		(1,155	)
Other liabilities		198			3,192

Net cash provided by operating activities		14,898			116,148

Cash flows from investing activities:
Acquisition of property, plant, and equipment		(51,703	)		(37,608	)
Proceeds from sale of assets		94			201
Proceeds from divestiture of businesses		-			36,790
Acquisition of new business		(1,048	)		(13,875	)
Other investing activities		947			1,348

Net cash used in investing activities		(51,710	)		(13,144	)

Cash flows from financing activities:
Proceeds from additional borrowings		187,715			55,589
Debt payments		(87,657	)		(67,534	)
Purchase of treasury stock		-			(31,467	)
Dividends paid		(51,681	)		(49,468	)
Other financing activities		(2,056	)		(582	)

Net cash provided by (used in) financing activities		46,321			(93,462	)

Effect of exchange rate changes on cash and cash equivalents		11,330			(1,373	)

Net increase in cash and cash equivalents		20,839			8,169
Cash and cash equivalents at beginning of period		25,740			24,770

Cash and cash equivalents at end of period	$	46,579		$	32,939

See accompanying notes to consolidated condensed financial statements.

Index

SENSIENT TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands, except share and per share amounts)

(Unaudited)

	Common		Additional Paid-In		Earnings Reinvested in the			Treasury Stock					Accumulated Other Comprehensive			Total
Three Months Ended Sept. 30, 2022	Stock		Capital		Business			Shares		Amount			Income (Loss)			Equity
Balances at June 30, 2022	$	5,396	$	116,596	$	1,672,000			12,058,773	$	(631,853	)	$	(203,172	)	$	958,967
Net earnings		-		-		36,048			-		-			-			36,048
Other comprehensive loss		-		-		-			-		-			(27,051	)		(27,051	)
Cash dividends paid – $0.41 per share		-		-		(17,235	)		-		-			-			(17,235	)
Share-based compensation		-		3,785		-			-		-			-			3,785
Balances at September 30, 2022	$	5,396	$	120,381	$	1,690,813			12,058,773	$	(631,853	)	$	(230,223	)	$	954,514

Three Months Ended Sept. 30, 2021

Balances at June 30, 2021	$	5,396	$	105,967	$	1,603,239		11,892,497	$	(614,404	)	$	(155,921	)	$	944,277
Net earnings		-		-		33,912		-		-			-			33,912
Other comprehensive loss		-		-		-		-		-			(15,232	)		(15,232	)
Cash dividends paid – $0.39 per share		-		-		(16,441	)	-		-			-			(16,441	)
Share-based compensation		-		2,243		-		-		-			-			2,243
Purchase of treasury stock		-		-		-		105,600		(9,367	)		-			(9,367	)
Balances at September 30, 2021	$	5,396	$	108,210	$	1,620,710		11,998,097	$	(623,771	)	$	(171,153	)	$	939,392

Nine Months Ended September 30, 2022

Balances at December 31, 2021	$	5,396	$	111,352		$	1,630,713		12,107,549		$	(634,408	)	$	(174,628	)	$	938,425
Net earnings		-		-			111,766		-			-			-			111,766
Other comprehensive loss		-		-			-		-			-			(55,595	)		(55,595	)
Cash dividends paid – $1.23 per share		-		-			(51,681	)	-			-			-			(51,681	)
Share-based compensation		-		12,476			-		-			-			-			12,476
Non-vested stock issued upon vesting		-		(3,239	)		-		(61,821	)		3,239			-			-
Benefit plans		-		560			-		(11,786	)		618			-			1,178
Other		-		(768	)		15		24,831			(1,302	)		-			(2,055	)
Balances at September 30, 2022	$	5,396	$	120,381		$	1,690,813		12,058,773		$	(631,853	)	$	(230,223	)	$	954,514

Nine Months Ended September 30, 2021

Balances at December 31, 2020	$	5,396	$	102,909		$	1,578,662		11,647,627		$	(593,540	)	$	(159,091	)	$	934,336
Net earnings		-		-			91,516		-			-			-			91,516
Other comprehensive loss		-		-			-		-			-			(12,062	)		(12,062	)
Cash dividends paid – $1.17 per share		-		-			(49,468	)	-			-			-			(49,468	)
Share-based compensation		-		6,431			-		-			-			-			6,431
Non-vested stock issued upon vesting		-		(1,264	)		-		(24,711	)		1,264			-			-
Benefit plans		-		338			-		(14,791	)		756			-			1,094
Purchase of treasury stock		-		-			-		382,593			(31,874	)		-			(31,874	)
Other		-		(204	)		-		7,379			(377	)		-			(581	)
Balances at September 30, 2021	$	5,396	$	108,210		$	1,620,710		11,998,097		$	(623,771	)	$	(171,153	)	$	939,392

See accompanying notes to consolidated condensed financial statements.

Index

SENSIENT TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(Unaudited)

1.	Accounting Policies

In the opinion of Sensient Technologies Corporation (the Company), the accompanying unaudited consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) that are necessary to present fairly the financial position of the Company as of September 30, 2022, and the results of operations, comprehensive income, and shareholders’ equity for the three and nine months ended September 30, 2022 and 2021, and cash flows for the nine months ended September 30, 2022 and 2021. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full year.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Expenses are charged to operations in the period incurred.

Recently Issued Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (FASB) issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions to GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other inter-bank offered rates to alternative rates. The guidance is effective upon issuance and generally can be applied through December 31, 2022. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and its related disclosures.

Please refer to the notes in the Company’s annual consolidated financial statements for the year ended December 31, 2021, for additional details of the Company’s financial condition and a description of the Company’s accounting policies, which have been continued without change.

2.	Divestitures

On June 30, 2020, the Company completed the sale of its inks product line. On September 18, 2020, the Company completed the sale of its yogurt fruit preparations product line. This sale also included an earnout based on future performance, which could result in additional cash consideration for the Company. On April 1, 2021, the Company completed the sale of its fragrances product line (excluding its essential oils product line) for $36.3 million of net cash.

The Company reports all costs associated with the divestitures in Corporate & Other. There were no costs associated with the divestitures for the three and nine months ended September 30, 2022.

The following table summarizes the divestiture & other related costs for the three months ended September 30, 2021:

(In thousands)		Yogurt Fruit Preparations				Fragrances				Inks				Corporate & Other				Total
Other costs - Selling and administrative expenses⁽¹⁾		$	102			$	149			$	(157	)		$	147			$	241

(1)

Other costs – Selling and administrative expenses include employee separation costs, professional services, accelerated depreciation, and other related costs and income.

The following table summarizes the divestiture & other related costs for the nine months ended September 30, 2021:

(In thousands)	Yogurt Fruit Preparations		Fragrances		Inks			Corporate & Other		Total
Non-cash impairment charges – Selling and administrative expenses	$	-	$	1,062	$	-		$	-	$	1,062
Non-cash charges – Cost of products sold		-		37		(9	)		-		28
Reclassification of foreign currency translation and related items – Selling and administrative expenses		-		10,193		-			-		10,193
Other costs - Selling and administrative expenses⁽¹⁾		631		1,365		(362	)		584		2,218
Total	$	631	$	12,657	$	(371	)	$	584	$	13,501

(1)

Other costs – Selling and administrative expenses include environmental remediation, employee separation costs, professional services, accelerated depreciation, and other related costs.

Index

In March 2020, the Company was notified by the buyer of the Company’s fragrances product line that environmental sampling conducted at the Company’s Granada, Spain location had identified the presence of contaminants in soil and groundwater in certain areas of the property. The Company records liabilities related to environmental remediation obligations when estimated future expenditures are probable and the amount of the liability is reasonably estimable. Based upon an environmental investigation and a quantitative risk assessment performed by a consultant hired by the Company, the Company recorded $0.3 million related to these obligations in Selling and Administrative Expenses during the nine months ended September 30, 2021.

3.	Operational Improvement Plan

During the third quarter of 2020, the Company approved an operational improvement plan (Operational Improvement Plan) to consolidate manufacturing facilities and improve efficiencies within the Company. As part of the Operational Improvement Plan, the Company combined its New Jersey cosmetics manufacturing facility in the Personal Care product line of the Color segment into its existing Color segment facility in Missouri. In addition, the Company centralized certain Flavors & Extracts segment support functions in Europe into one location. In the Asia Pacific segment, the Company incurred costs in connection with the elimination of certain selling and administrative positions.

The Company reports all costs and income associated with the Operational Improvement Plan in Corporate & Other. There were no costs associated with the Operational Improvement Plan for the three and nine months ended September 30, 2022.

The following table summarizes the Operational Improvement Plan expenses recorded in Selling and Administrative Expenses by segment for the three months ended September 30, 2021:

(In thousands)	Flavors & Extracts		Color			Asia Pacific			Consolidated
Employee separation costs	$	1	$	(120	)	$	(4	)	$	(123	)
Other costs⁽¹⁾		-		605			1			606
Total expense (income)	$	1	$	485		$	(3	)	$	483

(1)

Other costs include professional services, accelerated depreciation, and other related costs.

The following table summarizes the Operational Improvement Plan expenses recorded in Selling and Administrative Expenses by segment for the nine months ended September 30, 2021:

(In thousands)	Flavors & Extracts			Color			Asia Pacific			Consolidated
Employee separation costs	$	(15	)	$	(40	)	$	(72	)	$	(127	)
Other income⁽¹⁾		-			(3,624	)		-			(3,624	)
Other costs⁽²⁾		-			1,739			2			1,741
Total expense (income)	$	(15	)	$	(1,925	)	$	(70	)	$	(2,010	)

(1)

Other income includes cash received for the early termination of a lease less associated expenses.

(2)

Other costs include professional services, accelerated depreciation, and other related costs.

As of September 30, 2022 and December 31 2021, accrued liabilities in Other Accrued Expenses totaled $0.3 million and $0.8 million, respectively, related to the Operational Improvement Plan.

Index

4.	Acquisition

On July 15, 2021, the Company acquired substantially all of the assets of Flavor Solutions, Inc., a flavors business located in New Jersey. The purchase price for this acquisition was $14.9 million in cash. The assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. The Company acquired net assets of $0.4 million and identified intangible assets, principally customer relationships, of $5.0 million. The remaining $9.5 million was allocated to goodwill. This business is now part of the Flavors & Extracts segment.

5.	Trade Accounts Receivable

Trade accounts receivables are recorded at their face amount, less an allowance for expected losses on doubtful accounts. The allowance for doubtful accounts is calculated based on customer-specific analysis and an aging methodology using historical loss information. The Company believes historical loss information is a reasonable basis for expected credit losses as the Company’s historical credit loss experience correlates with its customer delinquency status. This information is also adjusted for any known current economic conditions, including the current and expected impact of COVID-19. Currently, the COVID-19 pandemic has not had and is not anticipated to have a material impact on trade accounts receivable. Forecasted economic conditions have not had a significant impact on the current credit loss estimate due to the short-term nature of the Company’s customer receivables; however, the Company will continue to monitor and evaluate the rapidly changing economic conditions. Additionally, as the Company only has one portfolio segment, there are not different risks between portfolios. Specific accounts are written off against the allowance for doubtful accounts when the receivable is deemed no longer collectible.

The following table summarizes the changes in the allowance for doubtful accounts during the three and nine month periods ended September 30, 2022 and 2021:

(In thousands) Three Months Ended September 30, 2022	Allowance for Doubtful Accounts
Balance at June 30, 2022	$	4,494
Provision for expected credit losses		51
Accounts written off		(33	)
Translation and other activity		(105	)
Balance at September 30, 2022	$	4,407

(In thousands) Three Months Ended September 30, 2021	Allowance for Doubtful Accounts
Balance at June 30, 2021	$	3,749
Provision for expected credit losses		186
Accounts written off		(41	)
Translation and other activity		(65	)
Balance at September 30, 2021	$	3,829

(In thousands) Nine Months Ended September 30, 2022	Allowance for Doubtful Accounts
Balance at December 31, 2021	$	4,877
Provision for expected credit losses		883
Accounts written off		(1,129	)
Translation and other activity		(224	)
Balance at September 30, 2022	$	4,407

(In thousands) Nine Months Ended September 30, 2021	Allowance for Doubtful Accounts
Balance at December 31, 2020	$	3,891
Provision for expected credit losses		480
Accounts written off		(414	)
Translation and other activity		(128	)
Balance at September 30, 2021	$	3,829

Index

6.	Inventories

At September 30, 2022, and December 31, 2021, inventories included finished and in-process products totaling $332.1 million and $280.2 million, respectively, and raw materials and supplies of $169.3 million and $131.4 million, respectively.

Debt

On August 31, 2022, the Company entered into Amendment No. 9 (Amendment) to the Receivables Purchase Agreement, dated as of October 3, 2016. The Amendment increased the facility limit from $30 million to $85 million and extended the maturity date from October 1, 2022 to August 31, 2023. The Amendment also changed the interest rate benchmark from the London Interbank Offered Rate to the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York and modified certain other provisions.

8.	Fair Value

Accounting Standards Codification 820, Fair Value Measurement, defines fair value for financial assets and liabilities, establishes a framework for measuring fair value in GAAP, and expands disclosures about fair value measurements. The carrying values of the Company’s cash and cash equivalents, trade accounts receivable, trade accounts payable, accrued expenses, and short-term borrowings were approximately the same as the fair values as of September 30, 2022 and December 31, 2021. The net fair value of the forward exchange contracts based on current pricing obtained for comparable derivative products (Level 2 inputs) was an asset of $0.3 million and $0.1 million as of September 30, 2022 and December 31, 2021, respectively. The fair value of the Company’s long-term debt, including current maturities, is estimated using discounted cash flows based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements (Level 2 inputs). The carrying value of the long-term debt at September 30, 2022 and December 31, 2021 was $547.7 million and $503.5 million, respectively. The fair value of the long-term debt at September 30, 2022 and December 31, 2021 was $539.1 million and $520.0 million, respectively.

9.	Segment Information

The Company evaluates performance based on operating income before divestiture & other related costs, share-based compensation, restructuring and other charges including the Operational Improvement Plan costs, interest expense, and income taxes (segment operating income). Total revenue and segment operating income by business segment and geographic region include both sales to customers, as reported in the Company’s Consolidated Statements of Earnings, and intersegment sales, which are accounted for at prices that approximate market prices and are eliminated in consolidation.

The Company determines its operating segments based on information utilized by its chief operating decision maker to allocate resources and assess performance. The Company’s three reportable segments are the Flavors & Extracts and Color segments, which are both managed on a product line basis, and the Asia Pacific segment, which is managed on a geographic basis. The Company’s Flavors & Extracts segment produces flavor, extracts, and essential oils products that impart a desired taste, texture, aroma, and other characteristics to a broad range of consumer and other products. The Color segment produces natural and synthetic color systems for use in foods, beverages, pharmaceuticals, and nutraceuticals; colors and other ingredients for cosmetics, such as active ingredients, solubilizers, and surface treated pigments; pharmaceutical and nutraceutical excipients, such as colors, flavors, coatings, and nutraceutical ingredients; and technical colors for industrial applications. The Asia Pacific segment is managed on a geographic basis and produces and distributes color and flavor products for the Asia Pacific countries. The Company’s corporate expenses, divestiture & other related costs, share-based compensation, operational improvement plan expenses, and other costs are included in the “Corporate & Other” category.

Divestiture & other related costs and restructuring and other costs, including the Operational Improvement Plan costs, for the three and nine months ended September 30, 2021, are further described in Note 2, Divestitures, and Note 3, Operational Improvement Plan, and are included in the operating income (loss) results in Corporate & Other below. There were no divestiture & other related costs or Operational Improvement Plan costs for the three and nine months ended September 30, 2022. In addition, the Company’s corporate expenses and share-based compensation are included in Corporate & Other.

Index

Operating results by segment for the periods presented are as follows:

(In thousands)	Flavors & Extracts		Color		Asia Pacific		Corporate & Other			Consolidated
Three months ended September 30, 2022:
Revenue from external customers	$	181,397	$	144,570	$	35,109	$	-		$	361,076
Intersegment revenue		5,649		6,899		112		-			12,660
Total revenue	$	187,046	$	151,469	$	35,221	$	-		$	373,736

Operating income (loss)	$	26,337	$	28,200	$	6,952	$	(13,996	)	$	47,493
Interest expense		-		-		-		3,672			3,672
Earnings (loss) before income taxes	$	26,337	$	28,200	$	6,952	$	(17,668	)	$	43,821

Three months ended September 30, 2021:
Revenue from external customers	$	175,690	$	135,395	$	33,202	$	-		$	344,287
Intersegment revenue		5,977		3,844		240		-			10,061
Total revenue	$	181,667	$	139,239	$	33,442	$	-		$	354,348

Operating income (loss)	$	25,164	$	27,253	$	6,601	$	(12,060	)	$	46,958
Interest expense		-		-		-		3,037			3,037
Earnings (loss) before income taxes	$	25,164	$	27,253	$	6,601	$	(15,097	)	$	43,921

(In thousands)	Flavors & Extracts		Color		Asia Pacific		Corporate & Other			Consolidated
Nine months ended September 30, 2022:
Revenue from external customers	$	539,014	$	440,568	$	108,721	$	-		$	1,088,303
Intersegment revenue		20,096		15,607		293		-			35,996
Total revenue	$	559,110	$	456,175	$	109,014	$	-		$	1,124,299

Operating income (loss)	$	83,929	$	90,035	$	22,877	$	(41,315	)	$	155,526
Interest expense		-		-		-		9,748			9,748
Earnings (loss) before income taxes	$	83,929	$	90,035	$	22,877	$	(51,063	)	$	145,778

Nine months ended September 30, 2021:
Revenue from external customers	$	545,050	$	395,426	$	99,340	$	-		$	1,039,816
Intersegment revenue		16,929		12,740		259		-			29,928
Total revenue	$	561,979	$	408,166	$	99,599	$	-		$	1,069,744

Operating income (loss)	$	76,718	$	79,462	$	19,146	$	(45,718	)	$	129,608
Interest expense		-		-		-		9,792			9,792
Earnings (loss) before income taxes	$	76,718	$	79,462	$	19,146	$	(55,510	)	$	119,816

Product Lines

(In thousands)	Flavors & Extracts			Color			Asia Pacific			Consolidated
Three months ended September 30, 2022:
Flavors, Extracts & Flavor Ingredients	$	123,945		$	-		$	-		$	123,945
Natural Ingredients		63,101			-			-			63,101
Food & Pharmaceutical Colors		-			111,194			-			111,194
Personal Care		-			39,689			-			39,689
Inks		-			586			-			586
Asia Pacific		-			-			35,221			35,221
Intersegment Revenue		(5,649	)		(6,899	)		(112	)		(12,660	)
Total revenue from external customers	$	181,397		$	144,570		$	35,109		$	361,076

Three months ended September 30, 2021:
Flavors, Extracts & Flavor Ingredients	$	116,140		$	-		$	-		$	116,140
Natural Ingredients		64,215			-			-			64,215
Yogurt Fruit Preparations		1,312			-			-			1,312
Food & Pharmaceutical Colors		-			99,688			-			99,688
Personal Care		-			39,241			-			39,241
Inks		-			310			-			310
Asia Pacific		-			-			33,442			33,442
Intersegment Revenue		(5,977	)		(3,844	)		(240	)		(10,061	)
Total revenue from external customers	$	175,690		$	135,395		$	33,202		$	344,287

Index

(In thousands)	Flavors & Extracts			Color			Asia Pacific			Consolidated
Nine months ended September 30, 2022:
Flavors, Extracts & Flavor Ingredients	$	381,041		$	-		$	-		$	381,041
Natural Ingredients		178,069			-			-			178,069
Food & Pharmaceutical Colors		-			328,087			-			328,087
Personal Care		-			126,651			-			126,651
Inks		-			1,437			-			1,437
Asia Pacific		-			-			109,014			109,014
Intersegment Revenue		(20,096	)		(15,607	)		(293	)		(35,996	)
Total revenue from external customers	$	539,014		$	440,568		$	108,721		$	1,088,303

Nine months ended September 30, 2021:
Flavors, Extracts & Flavor Ingredients	$	347,642		$	-		$	-		$	347,642
Natural Ingredients		186,721			-			-			186,721
Fragrances		22,739			-			-			22,739
Yogurt Fruit Preparations		4,877			-			-			4,877
Food & Pharmaceutical Colors		-			287,565			-			287,565
Personal Care		-			119,079			-			119,079
Inks		-			1,522			-			1,522
Asia Pacific		-			-			99,599			99,599
Intersegment Revenue		(16,929	)		(12,740	)		(259	)		(29,928	)
Total revenue from external customers	$	545,050		$	395,426		$	99,340		$	1,039,816

Geographic Markets

(In thousands)	Flavors & Extracts		Color		Asia Pacific		Consolidated
Three months ended September 30, 2022:
North America	$	142,097	$	74,220	$	27	$	216,344
Europe		26,795		34,591		44		61,430
Asia Pacific		7,091		16,770		34,433		58,294
Other		5,414		18,989		605		25,008
Total revenue from external customers	$	181,397	$	144,570	$	35,109	$	361,076

Three months ended September 30, 2021:
North America	$	131,855	$	67,830	$	5	$	199,690
Europe		30,241		37,004		30		67,275
Asia Pacific		6,410		14,451		32,511		53,372
Other		7,184		16,110		656		23,950
Total revenue from external customers	$	175,690	$	135,395	$	33,202	$	344,287

(In thousands)	Flavors & Extracts		Color		Asia Pacific		Consolidated
Nine months ended September 30, 2022:
North America	$	407,684	$	223,508	$	87	$	631,279
Europe		90,565		116,184		175		206,924
Asia Pacific		23,628		49,199		105,222		178,049
Other		17,137		51,677		3,237		72,051
Total revenue from external customers	$	539,014	$	440,568	$	108,721	$	1,088,303

Nine months ended September 30, 2021:
North America	$	390,163	$	188,764	$	67	$	578,994
Europe		107,463		112,188		106		219,757
Asia Pacific		24,288		47,832		96,863		168,983
Other		23,136		46,642		2,304		72,082
Total revenue from external customers	$	545,050	$	395,426	$	99,340	$	1,039,816

Index

10.	Retirement Plans

The Company’s components of annual benefit cost for the defined benefit plans for the periods presented are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
(In thousands)	2022			2021			2022			2021
Service cost	$	404		$	435		$	1,219		$	1,308
Interest cost		235			212			719			638
Expected return on plan assets		(194	)		(184	)		(598	)		(553	)
Recognized actuarial loss		12			69			36			207
Total defined benefit expense	$	457		$	532		$	1,376		$	1,600

The Company’s non-service cost portion of defined benefit expense is recorded in Interest Expense on the Company’s Consolidated Statements of Earnings. The Company’s service cost portion of defined benefit expense is recorded in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings.

11.	Derivative Instruments and Hedging Activity

The Company may use forward exchange contracts and foreign currency denominated debt to manage its exposure to foreign exchange risk in order to reduce the effect of fluctuating foreign currencies on short-term foreign currency denominated intercompany transactions, non-functional currency raw material purchases, non-functional currency sales, and other known foreign currency exposures. These forward exchange contracts generally have maturities of less than 18 months. The Company’s primary hedging activities and their accounting treatment are summarized below.

Forward exchange contracts – Certain forward exchange contracts have been designated as cash flow hedges. The Company had $35.6 million and $48.6 million of forward exchange contracts designated as cash flow hedges outstanding as of September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, amounts reclassified into net earnings in the Company’s Consolidated Statement of Earnings that offset the underlying transactions’ impact on earnings in the same period were not material. For the nine months ended September 30, 2022 and 2021, gains of $0.6 million and $1.1 million, respectively, were reclassified into net earnings in the Company’s Consolidated Statement of Earnings that offset the underlying transactions’ impact on earnings in the same period. In addition, the Company utilizes forward exchange contracts that are not designated as cash flow hedges. The results of these transactions were not material to the financial statements of the Company.

Net investment hedges – The Company has designated certain foreign currency denominated long-term borrowings as partial hedges of the Company’s foreign currency net asset positions. As of September 30, 2022 and December 31, 2021, the total value of the Company’s net investment hedges was $247.1 million and $289.5 million, respectively. These net investment hedges included Euro and British Pound denominated long-term debt. Changes in the fair value of this debt attributable to changes in the spot foreign exchange rate are recorded in foreign currency translation in Other Comprehensive Income (OCI). For the three months ended September 30, 2022 and 2021, the impact of foreign exchange rates on these debt instruments decreased debt by $18.4 million and $7.2 million, respectively, which has been recorded as foreign currency translation in OCI. For the nine months ended September 30, 2022 and 2021, the impact of foreign exchange rates on these debt instruments decreased debt by $42.4 million and $14.1 million, respectively, which has been recorded as foreign currency translation in OCI. For the nine months ended September 30, 2021, losses of $4.2 million were reclassified into net earnings in the Company’s Consolidated Statement of Earnings related to the Euro net investment hedge in connection with the sale of the fragrances product line. See Note 2, Divestitures, for additional information.

Index

12.	Income Taxes

The effective income tax rates for the three months ended September 30, 2022 and 2021, were 17.7% and 22.8%, respectively. For the nine months ended September 30, 2022 and 2021, the effective income tax rates were 23.3% and 23.6%, respectively. The effective tax rates for the three and nine months ended September 30, 2022 and 2021, were both impacted by changes in estimates associated with the finalization of prior year foreign tax items, the mix of foreign earnings, and changes in valuation allowances. The three and nine months ended September 30, 2021, were also impacted by audit settlements and changes in deferred tax assets and liabilities due to newly enacted tax rates.

13.	Accumulated Other Comprehensive Income

The following table summarizes the changes in OCI during the three and nine month periods ended September 30, 2022 and 2021:

(In thousands)	Cash Flow Hedges ⁽¹⁾			Pension Items ⁽¹⁾			Foreign Currency Items			Total
Balances at December 31, 2021	$	206		$	(353	)	$	(174,481	)	$	(174,628	)
Other comprehensive income (loss) before reclassifications		516			-			(55,514	)		(54,998	)
Amounts reclassified from OCI		(621	)		24			-			(597	)
Balances at September 30, 2022	$	101		$	(329	)	$	(229,995	)	$	(230,223	)

(In thousands)	Cash Flow Hedges ⁽¹⁾			Pension Items ⁽¹⁾			Foreign Currency Items			Total
Balances at June 30, 2022	$	(152)		$	(337	)	$	(202,683	)	$	(203,172	)
Other comprehensive income (loss) before reclassifications		380			-			(27,312	)		(26,932	)
Amounts reclassified from OCI		(127	)		8			-			(119	)
Balances at September 30, 2022	$	101		$	(329	)	$	(229,995	)	$	(230,223	)

(In thousands)	Cash Flow Hedges ⁽¹⁾			Pension Items ⁽¹⁾			Foreign Currency Items			Total
Balances at December 31, 2020	$	749		$	(1,965	)	$	(157,875	)	$	(159,091	)
Other comprehensive income (loss) before reclassifications		729			-			(22,073	)		(21,344	)
Amounts reclassified from OCI		(1,068	)		156			10,194			9,282
Balances at September 30, 2021	$	410		$	(1,809	)	$	(169,754	)	$	(171,153	)

(In thousands)	Cash Flow Hedges ⁽¹⁾			Pension Items ⁽¹⁾			Foreign Currency Items			Total
Balances at June 30, 2021	$	817		$	(1,861	)	$	(154,877	)	$	(155,921	)
Other comprehensive loss before reclassifications		(115	)		-			(14,877	)		(14,992	)
Amounts reclassified from OCI		(292	)		52			-			(240	)
Balances at September 30, 2021	$	410		$	(1,809	)	$	(169,754	)	$	(171,153	)

(1)

Cash Flow Hedges and Pension Items are net of tax.

14.	Commitments and Contingencies

Kelley v. Sensient Natural Ingredients LLC

Walters v. Sensient Natural Ingredients LLC

Sofia Rodriguez v. Sensient Natural Ingredients LLC and One Source Staffing Solutions, Inc.

Index

On March 4, 2020, Monique Kelley filed a Class Action Complaint against SNI in Merced County Superior Court in California. Ms. Kelley worked at SNI for less than a week in 2017 through a temporary staffing company. Ms. Kelley has brought suit for purported violations of the California Labor Code and the California Business and Professions Code on her own behalf, and on behalf of all current and former California-based hourly-paid or non-exempt employees of SNI. Ms. Kelley specifically asserts claims for unpaid overtime wages, unpaid minimum wages, unpaid meal and rest break premiums, failure to timely pay final wages upon termination, non-compliant wage statements, and unreimbursed business expenses. Following motion practice, Ms. Kelley amended her original pleading, asserting the same causes of action, and SNI filed a responsive pleading. The parties then entered the discovery process.

On April 26, 2021, the same law firm representing Ms. Kelley filed an additional notice with the State of California of the intent to pursue a claim on a representative basis pursuant to the California Private Attorneys General Act of 2004 (PAGA). This notice was served on behalf of Patrick Walters, an employee of SNI. The notice states the intent to pursue relief on behalf of Mr. Walters as well as other alleged aggrieved employees, identified as all current and former hourly or non-exempt employees of SNI, whether hired directly or through staffing agencies. The notice alleges that SNI failed to properly pay Mr. Walters and the other alleged aggrieved employees for all hours worked, failed to properly provide or compensate minimum and overtime wages and for meal and rest breaks, failed to issue compliant wage statements, and failed to reimburse for all necessary business-related expenses, in violation of the California Labor Code and California Industrial Welfare Commission Orders. On July 30, 2021, Mr. Walters filed a Complaint in Merced County Superior Court asserting the claims set forth in his PAGA notice. SNI filed its Answer and Affirmative Defenses in response.

On June 10, 2021, Sofia Rodriguez filed notice with the State of California of the intent to pursue a claim on a representative basis pursuant to PAGA. The notice was served on behalf of Ms. Rodriguez, who worked at SNI through One Source Staffing Solutions, Inc. for five months in 2020. The notice states the intent to pursue relief on behalf of Ms. Rodriguez as well as other alleged aggrieved employees, identified as all non-exempt employees who worked for Defendants in the State of California, and who were paid on an hourly basis. The notice alleges that SNI failed to allow Ms. Rodriguez and the other alleged aggrieved employees to take statutorily required meal and rest periods. The notice further alleges that Defendants suffered and permitted Ms. Rodriguez and other alleged aggrieved employees to work off the clock, failed to pay for all hours worked, failed to properly provide or compensate for minimum and overtime wages, failed to issue compliant wage statements, and failed to pay wages owed upon termination of employment, in violation of the California Labor Code. Ms. Rodriguez also asserts that she was taken off the schedule and not returned to work after complaining about the alleged wage and hour violations set forth in the PAGA notice. On August 17, 2021, Ms. Rodriguez filed a Complaint in Stanislaus County Superior Court asserting the claims set forth in her PAGA notice. SNI filed its Answer and Affirmative Defenses in response.

Previously, SNI had agreed to attempt a joint mediation of the Kelley, Walters, and Rodriguez matters, which was scheduled for August 2022. Before the mediation occurred, however, on June 15, 2022, the United States Supreme Court issued its decision in Viking River Cruises, Inc. v. Moriana, 596 U.S. ___ (2022), in which the Court ruled that the Federal Arbitration Act requires enforcement of an arbitration agreement that waives an employee’s right to bring individual claims under PAGA, and that an individual with such an agreement to arbitrate does not have standing to pursue the remaining non-individual claims in Court. As a result of the decision, SNI withdrew its agreement to mediate.

In the Walters case, SNI has demanded that Walters submit his individual PAGA claims to arbitration in accordance with his arbitration agreement. Pending litigation in the California Supreme Court concerning the standing issue addressed in Viking River Cruises may result in a stay of the Walters case. In the Kelley and Rodriguez cases, SNI will seek to compel individual arbitration as to any claims made on behalf of individuals with arbitration agreements. In addition, in the Kelley matter, SNI intends to seek summary judgment based upon a prior adjudication, in which Kelley settled claims that she now asserts against SNI. In the Rodriguez case, SNI also intends to seek indemnification and contribution from the staffing firm that supplied the temporary workers in question.

SNI intends to vigorously defend its interests in the Kelley, Walters, and Rodriguez matters, absent a reasonable resolution. Based upon the legal developments and defenses described above, and the Viking River Cruises decision, we no longer believe these proceedings are material to the business or the financial condition of the Company nor do we expect the liabilities, if any, which may ultimately result from such lawsuits to have a material adverse effect on our consolidated financial statements.

Index

Other Claims

The Company is subject to various claims and litigation arising in the normal course of business. The Company establishes reserves for claims and proceedings when it is probable that liabilities exist and reasonable estimates of loss can be made. While it is not possible to predict the outcome of these matters, based on our assessment of the facts and circumstances now known, we do not believe that these matters, individually or in the aggregate, will have a material adverse effect on our financial position. However, actual outcomes may be different from those expected and could have a material effect on our results of operations or cash flows in a particular period.

See Note 2, Divestitures, for information about estimated environmental remediation costs associated with our Granada, Spain location.

15.	Subsequent Events

On October 3, 2022, the Company acquired Endemix Doğal Maddeler A.Ş. and Teknoloji Yatırımları ve Danışmanlık Sanayi ve Ticaret A.Ş. (collectively, Endemix), a natural colors business located in Turkey. The Company paid $23.7 million in cash for this acquisition, which is net of $1.3 million in debt assumed, with $2.0 million of such amount being held back by the Company for 12 months in connection with the post-closing working capital adjustment and to satisfy any indemnification claims that may arise. This business will be part of the Colors segment.

On October 20, 2022, the Company announced its quarterly dividend of $0.41 per share would be payable on December 1, 2022.

Index

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that reflect management’s current assumptions and estimates of future economic circumstances, industry conditions, Company performance, and financial results. Forward-looking statements include statements in the future tense, statements referring to any period after September 30, 2022, and statements including the terms “expect,” “believe,” “anticipate,” and other similar terms that express expectations as to future events or conditions. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that could cause actual events to differ materially from those expressed in the forward-looking statements. A variety of factors could cause the Company’s actual results and experience to differ materially from the anticipated results. These factors and assumptions include, among others, the impact and uncertainty created by the COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost of labor, logistics, and transportation; governmental regulations and restrictions, and general economic conditions, including inflation; the uncertain impacts of the ongoing conflict between Russia and Ukraine on our supply chain, input costs, including energy and transportation, and on general economic conditions; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and the matters discussed under Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as updated and supplemented in Part II, Item 1A of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022. Except to the extent required by applicable law, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.

OVERVIEW

Revenue

Revenue was $361.1 million and $344.3 million for the three months ended September 30, 2022 and 2021, respectively. Revenue was $1.1 billion and $1.0 billion for the nine months ended September 30, 2022 and 2021, respectively. The increase in revenue for the three months ended September 30, 2022, was primarily due to higher selling prices. The increase in revenue for the nine months ended September 30, 2022, was primarily due to higher selling prices and volumes, partially offset by the sale of the Company’s Fragrances product line on April 1, 2021. For the three and nine months ended September 30, 2022, the impact of foreign exchange rates decreased consolidated revenue by approximately 4% and 3%, respectively.

Gross Margin

The Company’s gross margin was 33.7% and 33.4% for the three months ended September 30, 2022 and 2021, respectively. The Company’s gross margin was 34.7% and 32.9% for the nine months ended September 30, 2022 and 2021, respectively. The increase in gross margin for both the three and nine months ended September 30, 2022, was primarily due to increased pricing and volumes, partially offset by higher input costs and unfavorable product mix.

Selling and Administrative Expenses

Selling and administrative expense as a percent of revenue was 20.6% and 19.8% for the three months ended September 30, 2022 and 2021, respectively. Selling and administrative expense as a percent of revenue was 20.4% and 20.5% for the nine months ended September 30, 2022 and 2021, respectively.

Selling and administrative expenses for the three and nine months ended September 30, 2021, included divestiture & other related expenses and operational improvement plan costs and income totaling $0.7 million and $11.5 million, respectively. There were no divestiture & other related costs or operational improvement plan costs for the three or nine months ended September 30, 2022.

Index

The increase in selling and administrative expense as a percent of revenue for the three months ended September 30, 2022 is primarily due to higher performance-based executive compensation in 2022, partially offset by the lack of divestiture & other related costs and operational improvement plan costs in 2022. The decrease in selling and administrative expense as a percent of revenue for the nine months ended September 30, 2022, is primarily due to the lack of divestiture & other related costs and operational improvement plan costs in 2022, substantially offset by higher performance-based executive compensation in 2022. The divestiture & other related costs and operational improvement plan costs increased selling and administrative expense as a percent of revenue by 20 and 110 basis points for the three and nine months ended September 30, 2021, respectively.

Operating Income

Operating income was $47.5 million and $47.0 million for the three months ended September 30, 2022 and 2021, respectively. Operating margins were 13.2% and 13.6% for the three months ended September 30, 2022 and 2021, respectively. The decrease in operating margin is primarily due to higher input costs and unfavorable product mix, partially offset by higher pricing and volumes and the lack of divestiture & other related costs and operational improvement plan costs in the current period.

Operating income was $155.5 million and $129.6 million for the nine months ended September 30, 2022 and 2021, respectively. Operating margins were 14.3% and 12.5% for the nine months ended September 30, 2022 and 2021, respectively. The increase in operating margin is primarily due to higher pricing and volumes and the lack of divestiture & other related costs and operational improvement plan costs in the current period, partially offset by higher input costs and unfavorable product mix.

Interest Expense

Interest expense was $3.7 million and $3.0 million for the three months ended September 30, 2022 and 2021, respectively, and $9.7 million and $9.8 million for the nine months ended September 30, 2022 and 2021, respectively. The increase in expense for the three months ended September 30, 2022, was primarily due to a higher average debt balance and higher average interest rate compared to the comparable prior year period. The decrease in expense for the nine months ended September 30, 2022, was primarily due to the lower average interest rate in the current period compared to the comparable prior year period.

Income Taxes

Divestitures

For the three and nine months ended September 30, 2021, the Company incurred costs of $0.2 million and $13.5 million, respectively, related to the divestitures. The costs incurred in the nine month period primarily related to a non-cash net loss for the reclassification of accumulated foreign currency translation and related items from Accumulated Other Comprehensive Loss to Selling and Administrative Expenses in the Consolidated Statements of Earnings. There were no costs related to the divestitures incurred during the three or nine months ended September 30, 2022.

Operational Improvement Plan

During the second quarter of 2021, the Company received cash proceeds, net of associated expenses, in connection with the termination of a New Jersey office and laboratory space lease. The terminated lease was originally executed in November 2020 as part of the Operational Improvement Plan; however, the landlord for the property requested to terminate the lease prior to the end of its term and compensated the Company as part of a negotiated resolution for that termination.

Index

In the three and nine months ended September 30, 2021, the Company recorded costs of $0.5 million and income of $2.0 million, respectively, related to the Operational Improvement Plan. The income in the nine month period primarily related to the gain associated with the terminated New Jersey lease. There were no costs or income related to the Operational Improvement Plan incurred during the three or nine months ended September 30, 2022.

Acquisition

COVID-19

COVID-19 has adversely affected most of the world through widespread illness, quarantines, factory shutdowns, and travel and transportation disruptions and restrictions. These adverse effects could continue in parts of the world. While the Company’s financial position remains strong, the Company has seen several financial and operational impacts from the pandemic as of this filing. We have experienced various degrees of supply chain challenges and attempted to mitigate those challenges by increasing inventory in certain key raw materials and using secondary suppliers and new methods of procurement where available. In addition, we have experienced inflationary increases in costs associated with certain raw materials, logistics, energy, transportation, and labor. In response, we have taken pricing actions to offset these increases.

For the three and nine months ended September 30, 2022, demand for many of the Company’s products remained strong. All of the Company’s production facilities are open and operating as of this filing, but the Company continues to monitor developments and regulations in regions where its production facilities are located. Governmental and social responses to the COVID-19 pandemic continue to evolve. There continues to be uncertainty related to the impacts of new COVID-19 variants, and we expect that the situation will remain dynamic and difficult to predict for the foreseeable future. There can be no assurance that our experience to date with respect to facility operations, customer demand, the availability of supplies and transportation, and other factors impacting our results and financial condition will be predictive of the ongoing impacts in the short or long term. It is difficult to predict how economic conditions and changes in customer and consumer behavior may impact our results over the longer term. As a result of any of the foregoing, our results or financial condition could be adversely impacted and the impacts could be material.

NON-GAAP FINANCIAL MEASURES

Within the following tables, the Company reports certain non-GAAP financial measures, including: (1) adjusted revenue, adjusted operating income, adjusted net earnings, and adjusted diluted earnings per share, which exclude the results of the divested product lines, the divestiture & other related costs, and the operational improvement plan costs and income and (2) percentage changes in revenue, operating income, and diluted earnings per share on an adjusted local currency basis, which eliminate the effects that result from translating its international operations into U.S. dollars, the results of the divested product lines, the divestiture & other related costs, and the operational improvement plan costs or income.

The Company has included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this report. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and the Company believes the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.

Index

	Three Months Ended September 30,								Nine Months Ended September 30,
(In thousands, except per share amounts)	2022		2021			% Change			2022		2021			% Change
Revenue (GAAP)	$	361,076	$	344,287			4.9	%	$	1,088.303	$	1,039,816			4.7	%
Revenue of the divested product lines		-		(1,622	)					-		(29,399	)
Adjusted revenue	$	361,076	$	342,665			5.4	%	$	1,088,303	$	1,010,417			7.7	%

Operating Income (GAAP)	$	47,493	$	46,958			1.1	%	$	155,526	$	129,608			20.0	%
Divestiture & other related costs – Cost of products sold		-		-						-		28
Divestiture & other related costs – Selling and administrative expenses		-		241						-		13,473
Operating loss (income) of the divested product lines		-		70						-		(2,398	)
Operational improvement plan – Selling and administrative expenses (income)		-		483						-		(2,010	)
Adjusted operating income	$	47,493	$	47,752			(0.5	%)	$	155,526	$	138,701			12.1	%

Net Earnings (GAAP)	$	36,048	$	33,912			6.3	%	$	111,766	$	91,516			22.1	%
Divestiture & other related costs, before tax		-		241						-		13,501
Tax impact of divestiture & other related costs⁽¹⁾		-		1,179						-		283
Net loss (earnings) of the divested product lines, before tax		-		70						-		(2,398	)
Tax impact of the divested product lines⁽¹⁾		-		(18	)					-		590
Operational improvement plan costs (income), before tax		-		483						-		(2,010	)
Tax impact of operational improvement plan⁽¹⁾		-		(115	)					-		44
Adjusted net earnings	$	36,048	$	35,752			0.8	%	$	111,766	$	101,526			10.1	%

Diluted earnings per share (GAAP)	$	0.85	$	0.80			6.3	%	$	2.65	$	2.16			22.7	%
Divestiture & other related costs, net of tax		-		0.03						-		0.33
Results of operations of the divested product lines, net of tax		-		-						-		(0.04	)
Operational improvement plan costs (income, net of tax		-		0.01						-		(0.05	)
Adjusted diluted earnings per share	$	0.85	$	0.85			0.0	%	$	2.65	$	2.40			10.4	%

(1)

Tax impact adjustments were determined based on the nature of the underlying non-GAAP adjustments and their relevant jurisdictional tax rates.

Divestiture & other related costs are discussed under “Divestitures” above and Note 2, Divestitures, in the Notes to the Consolidated Condensed Financial Statements included in this report. The Operational Improvement Plan is discussed under “Operational Improvement Plan” above and Note 3, Operational Improvement Plan, in the Notes to the Consolidated Condensed Financial Statements included in this report.

Note: Earnings per share calculations may not foot due to rounding differences.

Index

The following table summarizes the percentage change for the results of the three and nine months ended September 30, 2022, compared to the results for the three and nine months ended September 30, 2021, in the respective financial measures.

	Three Months Ended September 30, 2022												Nine Months Ended September 30, 2022
Revenue	Total			Foreign Exchange Rates			Adjustments⁽¹⁾			Adjusted Local Currency			Total			Foreign Exchange Rates			Adjustments⁽¹⁾			Adjusted Local Currency
Flavors & Extracts		3.0	%		(2.9	%)		(0.8	%)		6.7	%		(0.5	%)		(2.4	%)		(5.0	%)		6.9	%
Color		8.8	%		(5.5	%)		(0.3	%)		14.6	%		11.8	%		(3.8	%)		(0.4	%)		16.0	%
Asia Pacific		5.3	%		(9.2	%)		0.0	%		14.5	%		9.5	%		(7.4	%)		(0.3	%)		17.2	%
Total Revenue		4.9	%		(4.4	%)		(0.6	%)		9.9	%		4.7	%		(3.3	%)		(3.0	%)		11.0	%

Operating Income
Flavors & Extracts		4.7	%		(1.1	%)		0.2	%		5.6	%		9.4	%		(1.2	%)		(4.0	%)		14.6	%
Color		3.5	%		(7.4	%)		0.0	%		10.9	%		13.3	%		(4.9	%)		0.9	%		17.3	%
Asia Pacific		5.3	%		(11.0	%)		0.0	%		16.3	%		19.5	%		(9.6	%)		(0.5	%)		29.6	%
Corporate & Other		16.0	%		(0.1	%)		(7.4	%)		23.5	%		(9.6	%)		0.0	%		(30.4	%)		20.8	%
Total Operating Income		1.1	%		(6.5	%)		1.8	%		5.8	%		20.0	%		(5.1	%)		8.4	%		16.7	%
Diluted Earnings per Share		6.3	%		(6.3	%)		5.5	%		7.1	%		22.7	%		(5.1	%)		12.8	%		15.0	%

(1)

For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income and Diluted Earnings per Share, adjustments consist of the results of the divested product lines, divestiture & other related costs, and operational improvement plan costs and income.

Note: Refer to table above for a reconciliation of these non-GAAP measures.

SEGMENT INFORMATION

The Company determines its operating segments based on information utilized by its chief operating decision maker to allocate resources and assess performance. Segment performance is evaluated on operating income before any applicable divestiture & other related costs, share-based compensation, acquisition, restructuring including the Operational Improvement Plan, and other costs (which are reported in Corporate & Other), interest expense, and income taxes.

The Company’s reportable segments consist of the Flavors & Extracts, Color, and Asia Pacific segments.

Flavors & Extracts

Flavors & Extracts segment revenue was $187.0 million and $181.7 million for the three months ended September 30, 2022 and 2021, respectively, an increase of approximately 3%. Foreign exchange rates decreased segment revenue by approximately 3%. The increase was primarily a result of higher revenue in Flavors, Extracts & Flavor Ingredients, offset by lower revenue in Natural Ingredients and lower revenue due to the completion of post-closing activities associated with the divestiture of Yogurt Fruit Preparations. The higher revenue in Flavors, Extracts & Flavor Ingredients was primarily due to higher selling prices and higher volumes, partially offset by the unfavorable impact of foreign exchange rates. The lower revenue in Natural Ingredients was primarily due to lower volumes, partially offset by higher selling prices.

Flavors & Extracts segment revenue was $559.1 million and $562.0 million for the nine months ended September 30, 2022 and 2021, respectively, a decrease of approximately 1%. Foreign exchange rates decreased segment revenue by approximately 2%. The decrease was primarily a result of lower revenue due to the completion of post-closing activities associated with the divestiture of Yogurt Fruit Preparations and the divestiture of Fragrances and lower revenue in Natural Ingredients, partially offset by higher revenue in Flavors, Extracts & Flavor Ingredients. The lower revenue in Natural Ingredients was primarily due to lower volumes, partially offset by higher selling prices. The higher revenue in Flavors, Extracts & Flavor Ingredients was primarily due to higher selling prices, higher volumes, and the acquisition of Flavor Solutions, Inc. in July of 2021, partially offset by the unfavorable impact of foreign exchange rates.

Flavors & Extracts segment operating income was $26.3 million and $25.2 million for the three months ended September 30, 2022 and 2021, respectively, an increase of approximately 5%. Foreign exchange rates decreased segment operating income by approximately 1%. The higher segment operating income was primarily a result of higher operating income in Flavors, Extracts & Flavor Ingredients primarily due to higher selling prices and higher volumes, partially offset by higher raw material costs and higher manufacturing and other costs. Segment operating income as a percent of revenue was 14.1% in the current quarter compared to 13.9% in the prior year’s comparable quarter.

Flavors & Extracts segment operating income was $83.9 million and $76.7 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of approximately 9%. Foreign exchange rates decreased segment operating income by approximately 1%. The increase was primarily a result of higher segment operating income in Flavors, Extracts & Flavor Ingredients and Natural Ingredients, partially offset by lower segment operating income due to the divestiture of Fragrances in April of 2021. The higher segment operating income in Flavors, Extracts & Flavor Ingredients was primarily a result of higher selling prices and volumes, partially offset by higher raw material costs, higher manufacturing and other costs, and the unfavorable impact of foreign exchange rates. The higher segment operating income in Natural Ingredients was primarily a result of higher selling prices and favorable product mix, partially offset by lower volumes, higher raw material costs, and higher manufacturing and other costs. Segment operating income as a percent of revenue was 15.0% in the current nine month period compared to 13.7% in the prior year’s comparable nine month period.

Index

Color

Segment revenue for the Color segment was $151.5 million and $139.2 million for the three months ended September 30, 2022 and 2021, respectively, an increase of approximately 9%. The increase was a result of higher revenue in Food & Pharmaceutical Colors, primarily due to higher volumes and selling prices, partially offset by the unfavorable impact of foreign exchange rates that decreased segment revenue by approximately 6%.

Segment revenue for the Color segment was $456.2 million and $408.2 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of approximately 12%. The increase was a result of higher revenue in Food & Pharmaceutical Colors and Personal Care, primarily due to higher volumes and selling prices, partially offset by the unfavorable impact of foreign exchange rates that decreased segment revenue by approximately 4%.

Segment operating income for the Color segment was $28.2 million and $27.3 million for the three months ended September 30, 2022 and 2021, respectively, an increase of approximately 4%. Foreign exchange rates decreased segment operating income by approximately 7%. The increase in segment operating income was a result of higher operating income in Food & Pharmaceutical Colors and Personal Care, primarily due to higher selling prices and volumes, partially offset by higher raw material costs, higher manufacturing and other costs, unfavorable product mix, and the unfavorable impact of foreign exchange rates. Segment operating income as a percent of revenue was 18.6% in the current quarter and 19.6% in the prior year’s comparable quarter.

Segment operating income for the Color segment was $90.0 million and $79.5 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of approximately 13%. Foreign exchange rates decreased segment operating income by approximately 5%. The increase in segment operating income was a result of higher operating income in Food & Pharmaceutical Colors and Personal Care, primarily due to higher selling prices and volumes, partially offset by higher raw material costs, higher manufacturing and other costs, unfavorable product mix, and the unfavorable impact of foreign exchange rates. Segment operating income as a percent of revenue was 19.7% in the current nine month period and 19.5% in the prior year’s comparable period.

Asia Pacific

Segment revenue for the Asia Pacific segment was $35.2 million and $33.4 million for the three months ended September 30, 2022 and 2021, respectively, an increase of approximately 5%. The increase was a result of higher volumes and selling prices, partially offset by the unfavorable impact of foreign exchange rates that decreased segment revenue by approximately 9%.

Segment revenue for the Asia Pacific segment was $109.0 million and $99.6 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of approximately 10%. The increase was a result of higher volumes and selling prices, partially offset by the unfavorable impact of foreign exchange rates, which decreased segment revenue by approximately 7%.

Segment operating income for the Asia Pacific segment was $7.0 million and $6.6 million for the three months ended September 30, 2022 and 2021, respectively, an increase of approximately 5%. The increase was primarily a result of higher volumes and selling prices, partially offset by higher other operating costs and the unfavorable impact of foreign exchange rates that decreased segment operating income by approximately 11%. Segment operating income as a percent of revenue was 19.7% in both the current quarter and the prior year’s comparable quarter.

Segment operating income for the Asia Pacific segment was $22.9 million and $19.1 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of approximately 20%. The increase was primarily a result of higher volumes and selling prices, partially offset by higher raw material and other operating costs, unfavorable product mix, and the unfavorable impact of foreign exchange rates that decreased segment operating income by approximately 10%. Segment operating income as a percent of revenue was 21.0% in the current nine month period and 19.2% in the prior year’s comparable period.

Corporate & Other

The Corporate & Other operating expense was $14.0 million and $12.1 million for the three months ended September 30, 2022 and 2021, respectively. The increase was primarily due to higher performance-based executive compensation in 2022, partially offset by the prior year including divestiture & other related costs and operational improvement plan costs. There were no divestiture & other related expenses or operational improvement plan income or costs in the current period.

Index

The Corporate & Other operating expense was $41.3 million and $45.7 million for the nine months ended September 30, 2022 and 2021, respectively. The decrease was primarily due to the prior period including divestiture & other related expenses of $13.5 million, partially offset by higher performance-based executive compensation in 2022 and the prior period including operational improvement plan income of $2.0 million. There were no divestiture & other related expenses or operational improvement plan income or costs in the current nine-month period.

LIQUIDITY AND FINANCIAL CONDITION

Financial Condition

The Company’s financial position remains strong. The Company is in compliance with its loan covenants calculated in accordance with applicable agreements as of September 30, 2022. The Company expects its cash flow from operations and its existing debt capacity can be used to meet anticipated future cash requirements for operations, capital expenditures, dividend payments, acquisitions, and stock repurchases. The Company’s contractual obligations consist primarily of operational commitments, which we expect to continue to be able to satisfy through cash generated from operations and debt. The Company has various series of notes outstanding that mature from 2022 through 2027. The Company believes that it has the ability to refinance or repay these obligations through a combination of cash flow from operations, issuance of additional notes, and substantial borrowing capacity under the Company’s revolving credit facility, which matures in 2026.

As a result of our ability to manage the impact of inflation through pricing and other actions, the impact of inflation was not material to the Company’s financial position and its results of operations for the three or nine months ended September 30, 2022. The Company currently anticipates inflation will not significantly impact the remainder of 2022, as a result of the Company’s pricing and other actions; however, the Company, like others in its industry, has faced challenges due to conditions in the global supply chain and global economy. In particular, the Company has experienced increased costs for certain inputs, such as energy, raw materials, shipping and logistics, and labor-related costs. We continue to expect to manage these impacts in the near term, but persistent, accelerated, or expanded inflationary conditions could exacerbate these challenges and impact our profitability.

Cash Flows from Operating Activities

Net cash provided by operating activities was $14.9 million and $116.1 million for the nine months ended September 30, 2022 and 2021, respectively. The decrease in net cash from operating activities was primarily due to an increase in cash used for inventory in 2022 as the Company invested in its inventory position to support demand and address supply chain challenges.

Cash Flows from Investing Activities

Net cash used in investing activities was $51.7 million and $13.1 million during the nine months ended September 30, 2022 and 2021, respectively. During the nine months ended September 30, 2021, the Company received cash proceeds of $36.8 million related to the Company’s divestiture activities. During the nine months ended September 30, 2022 and 2021, the Company paid $1.0 million and $13.9 million related to the acquisition of Flavors Solutions, Inc., respectively. Capital expenditures were $51.7 million and $37.6 million during the nine months ended September 30, 2022 and 2021, respectively.

Cash Flows from Financing Activities

Net cash provided by financing activities was $46.3 million for the nine months ended September 30, 2022, and net cash used in financing activities was $93.5 million for the nine months ended September 30, 2021. Net debt increased by $100.1 million and decreased by $11.9 million for the nine months ended September 30, 2022 and 2021, respectively. The cash proceeds from the increase in net debt in the current period were primarily used to support inventory investments during the nine months ended September 30, 2022. For purposes of the cash flow statement, net changes in debt exclude the impact of foreign exchange rates. The Company repurchased shares of its common stock for $31.5 million during the nine months ended September 30, 2021. There were no repurchases of shares of the Company’s common stock in 2022. Dividends of $51.7 million and $49.5 million were paid during the nine months ended September 30, 2022 and 2021, respectively. Dividends paid were $1.23 and $1.17 per share for the nine months ended September 30, 2022 and 2021, respectively.

Index

CRITICAL ACCOUNTING POLICIES

There have been no material changes in the Company’s critical accounting policies during the quarter ended September 30, 2022. For additional information about the Company’s critical accounting policies, refer to “Critical Accounting Policies” under Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the Company’s exposure to market risk during the quarter ended September 30, 2022. For additional information about market risk, refer to Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures: The Company carried out an evaluation, under the supervision and with the participation of management, including the Company’s Chairman, President, and Chief Executive Officer and its Senior Vice President and Chief Financial Officer, of the effectiveness, as of the end of the period covered by this report, of the design and operation of the disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based upon that evaluation, the Company’s Chairman, President, and Chief Executive Officer and its Senior Vice President and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting: During the quarter ended September 30, 2022, the Company upgraded an enterprise resource planning software application used in two business units within the Flavors & Extracts segment. The upgrade included order taking, manufacturing, general ledger, and financial reporting processes. For the system change, the Company followed an implementation process that required significant pre-implementation planning, design, and testing. There have been no other changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II.

OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

See Part I, Item 1, Note 14, Commitments and Contingencies, of this report for information regarding legal proceedings in which the Company is involved.

ITEM 1A.

RISK FACTORS

There were no material changes to the risk factors previously disclosed in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as updated and supplemented in Part II, Item 1A of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On October 19, 2017, the Board of Directors authorized the repurchase of up to three million shares (2017 Authorization). As of September 30, 2022, 1,267,019 shares had been repurchased under the 2017 Authorization. There is no expiration date for the 2017 Authorization. The 2017 Authorization may be modified, suspended, or discontinued by the Board of Directors at any time. As of September 30, 2022, the maximum number of shares that may be purchased under publicly announced plans is 1,732,981. No shares were purchased by the Company during the three or nine months ended September 30, 2022.

ITEM 6.

EXHIBITS

See Exhibit Index following this report.

Index

SENSIENT TECHNOLOGIES CORPORATION

EXHIBIT INDEX

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2022

Exhibit	Description	Incorporated by Reference From	Filed Herewith

10.1	Amendment No. 9 to Receivables Purchase Agreement, dated as of August 31, 2022, among Sensient Receivables LLC, Sensient Technologies Corporation, and Wells Fargo Bank, National Association.	Exhibit 10.1 to Current Report on Form 8-K filed September 6, 2022 (Commission File No. 1-7626)

31	Certifications of the Company’s Chairman, President & Chief Executive Officer and Senior Vice President & Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act		X

32	Certifications of the Company’s Chairman, President & Chief Executive Officer and Senior Vice President & Chief Financial Officer pursuant to 18 United States Code § 1350		X

101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)		X

101.SCH	Inline XBRL Taxonomy Extension Schema Document		X

101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document		X

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document		X

101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document		X

101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document		X

104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)		X

Index

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SENSIENT TECHNOLOGIES CORPORATION

Date:	November 1, 2022	By:	/s/ John J. Manning
			John J. Manning, Senior Vice President, General Counsel & Secretary

Date:	November 1, 2022	By:	/s/ Stephen J. Rolfs
			Stephen J. Rolfs, Senior Vice President & Chief Financial Officer

			Page No.

PART I. FINANCIAL INFORMATION:

	Item 1.	Financial Statements:

		Consolidated Statements of Earnings ‑ Three and Nine Months Ended September 30, 2022 and 2021.	1

		Consolidated Condensed Statements of Comprehensive Income ‑ Three and Nine Months Ended September 30, 2022 and 2021.	2

		Consolidated Balance Sheets - September 30, 2022 and December 31, 2021.	3

		Consolidated Statements of Cash Flows ‑ Nine Months Ended September 30, 2022 and 2021.	4

		Consolidated Statements of Shareholders’ Equity ‑ Three and Nine Months Ended September 30, 2022 and 2021.	5

		Notes to Consolidated Condensed Financial Statements.	6

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	16

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	23

	Item 4.	Controls and Procedures.	23

PART II. OTHER INFORMATION:

	Item 1.	Legal Proceedings.	23

	Item 1A.	Risk Factors.	23

	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	23

	Item 6.	Exhibits.	23

		Exhibit Index.	24

		Signatures.	25